|
|
Volumn 114, Issue 6, 2016, Pages 612-615
|
|
Derived neutrophil lymphocyte ratio is predictive of survival from intermittent therapy in advanced colorectal cancer: a post hoc analysis of the MRC COIN study
a
b
c
b
b
d
e
|
|
Author keywords
colorectal cancer; intermittent therapy; neutrophil lymphocyte ratio; predictive; prognostic
|
|
Indexed keywords
ALKALINE PHOSPHATASE;
CETUXIMAB;
FLUOROPYRIMIDINE;
OXALIPLATIN;
5-FLUOROPYRIMIDINE;
ANTINEOPLASTIC AGENT;
PLATINUM COMPLEX;
PYRIMIDINE DERIVATIVE;
ADD ON THERAPY;
ADULT;
ADVANCED CANCER;
AGED;
ALKALINE PHOSPHATASE BLOOD LEVEL;
ARTICLE;
CANCER COMBINATION CHEMOTHERAPY;
CANCER PATIENT;
CANCER PROGNOSIS;
CLINICAL EVALUATION;
COLORECTAL CANCER;
CONTROLLED STUDY;
DIAGNOSTIC TEST ACCURACY STUDY;
DRUG EFFICACY;
DRUG INTERMITTENT THERAPY;
FEMALE;
HAZARD RATIO;
HUMAN;
HUMAN CELL;
KAPLAN MEIER METHOD;
LEUKOCYTE COUNT;
LIVER METASTASIS;
MAJOR CLINICAL STUDY;
MALE;
MEDIAN SURVIVAL TIME;
MIDDLE AGED;
NEUTROPHIL COUNT;
NEUTROPHIL LYMPHOCYTE RATIO;
OVERALL SURVIVAL;
POST HOC ANALYSIS;
PREDICTIVE VALUE;
PRIORITY JOURNAL;
PROPORTIONAL HAZARDS MODEL;
RANDOMIZED CONTROLLED TRIAL;
SENSITIVITY AND SPECIFICITY;
SURVIVAL RATE;
THROMBOCYTE COUNT;
TREATMENT OUTCOME;
ADOLESCENT;
BLOOD;
CLINICAL TRIAL;
COLORECTAL NEOPLASMS;
DRUG ADMINISTRATION;
LYMPHOCYTE;
NEUTROPHIL;
PATHOLOGY;
PHASE 3 CLINICAL TRIAL;
PROGNOSIS;
VERY ELDERLY;
YOUNG ADULT;
ADOLESCENT;
ADULT;
AGED;
AGED, 80 AND OVER;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
CETUXIMAB;
COLORECTAL NEOPLASMS;
DRUG ADMINISTRATION SCHEDULE;
FEMALE;
HUMANS;
LEUKOCYTE COUNT;
LYMPHOCYTES;
MALE;
MIDDLE AGED;
NEUTROPHILS;
ORGANOPLATINUM COMPOUNDS;
PREDICTIVE VALUE OF TESTS;
PROGNOSIS;
PROPORTIONAL HAZARDS MODELS;
PYRIMIDINES;
SURVIVAL RATE;
YOUNG ADULT;
|
|
EID: 84958818605
PISSN: 00070920
EISSN: 15321827
Source Type: Journal
DOI: 10.1038/bjc.2016.23 Document Type: Article |
|
Times cited : (55)
|
|
References (8)
|
